Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	14,102	14,422	7,313	7,592	8,214	2,085
Market Cap Growth	97.22%	97.22%	-3.68%	-7.58%	293.91%	353.56%
Enterprise Value	12,907	13,741	6,290	7,175	7,748	1,574
Last Close Price	212.26	217.20	109.31	113.28	122.57	30.19
PE Ratio	25.82	26.05	32.55	28.41	43.57	12.23
PS Ratio	5.25	5.37	3.50	3.21	3.78	1.11
PB Ratio	5.88	6.01	3.90	4.78	6.19	1.71
P/TBV Ratio	9.14	9.35	3.90	4.78	6.19	1.71
P/FCF Ratio	25.66	26.24	20.94	16.39	140.06	7.51
P/OCF Ratio	25.50	26.08	20.80	16.27	118.81	7.39
EV/Sales Ratio	4.80	5.11	3.01	3.03	3.56	0.84
EV/EBITDA Ratio	25.27	26.91	28.37	20.67	30.37	7.92
EV/EBIT Ratio	30.06	32.00	29.03	21.18	32.30	8.38
EV/FCF Ratio	23.49	25.01	18.01	15.49	132.10	5.67
Debt / Equity Ratio	0.04	0.04	0.05	0.04	-	0.06
Debt / EBITDA Ratio	0.18	0.18	0.38	0.17	-	0.34
Debt / FCF Ratio	0.17	0.17	0.26	0.13	-	0.25
Asset Turnover	1.09	1.09	1.01	1.32	1.33	1.20
Inventory Turnover	6.39	6.39	4.52	3.68	3.02	2.75
Quick Ratio	5.48	5.48	8.31	4.92	2.32	1.89
Current Ratio	6.22	6.22	10.42	5.97	4.04	2.98
Return on Equity (ROE)	25.91%	25.91%	12.97%	18.32%	14.81%	14.64%
Return on Assets (ROA)	10.84%	10.84%	6.57%	11.79%	9.13%	7.51%
Return on Capital (ROIC)	12.05%	12.05%	7.50%	14.23%	11.47%	9.54%
Return on Capital Employed (ROCE)	17.00%	17.00%	10.90%	20.20%	17.50%	15.20%
Earnings Yield	3.93%	3.84%	3.07%	3.52%	2.30%	8.18%
FCF Yield	3.90%	3.81%	4.78%	6.10%	0.71%	13.31%
Dividend Yield	1.18%	1.15%	1.83%	1.76%	1.31%	1.32%
Payout Ratio	23.90%	23.90%	58.31%	-	55.58%	15.36%
Buyback Yield / Dilution	-1.46%	-1.46%	-1.35%	-	-	-
Total Shareholder Return	-0.29%	-0.31%	0.48%	1.76%	1.31%	1.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.